Owens & Minor (NYSE:OMI) said this month that it named former Thermo Fisher Scientific chief commercial officer Edward Pesicka as its new prez & CEO, effective March 4. Pesicka will replace interim prez & CEO Robert Sledd, who will continue to serve as board chair, the Richmond, Va.-based company said. Prior to his position as chief […]
JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019
JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]
Abbott promotes Ford to COO | Personnel Moves – October 15, 2018
Abbott (NYSE:ABT) said today that it promoted the head of its medical device division, the healthcare giant’s largest segment, to be its new operations chief. In naming former medical devices VP Robert Ford as COO, Abbott said Ford oversaw the integration of St. Jude Medical and was instrumental in the debut of Abbott’s FreeStyle Libre […]
Report: Amazon adds MGH cardiologist Majmudar | Personnel Moves – August 21, 2018
Amazon (NSDQ:AMZN) has picked up well-known cardiologist Dr. Maulik Majmudar for a new role within the company as it looks to continue its foray into healthcare, according to a recent CNBC report. The announcement was made by Majmudar himself on Twitter, according to the report, though he did not state what his specific role within the […]
NinePoint Medical lifts Namati to the corner office | Personnel Moves – July 10, 2018
NinePoint Medical said earlier this month that it appointed Eman Namati as its new president and chief executive officer, succeeding Christopher von Jako who will remain on the company’s board of directors. Namati joined NinePoint Medical at its inception in 2010 as a technical co-founder, and operated as R&D VP for the past four years, […]
Xtant Medical plans refinancing, 12-to-1 reverse stock split
Xtant Medical (NYSE:XTNT) said today it launched restructuring and refinancing efforts, including a 12-to-1 reverse stock split, as it looks to reform its capital structure, meet liquidity needs, regain compliance with the NYSE and position itself for better long-term growth. The efforts include inking a restructuring and exchange agreement with ROS Acquisition Offshore, OrbiMed Royalty Opportunities […]
NASS 2017 Roundup: Zimmer Biomet launches Vitality+, Vital spinal fixation systems
Zimmer Biomet (NYSE:ZBH) today announced the launch of its Vitality+ and Vital spine fixation systems in the US following recent 510(k) clearance for pedicle preparation and screw insertion under power. The Vitality+ spinal fixation system is composed of a Vitality+ Power designed for controlled pedicle preparation and pedicle screw insertion, Vitality+ PSO designed for optimal pedicle […]
Xtant Medical to shut down Dayton, Ohio facility
Xtant Medical (NYSE:XTNT) said today that it plans to close its Dayton, Ohio facility and transition its operations to the company’s headquarters in Belgrade, Montana. The Dayton facility employs 55 people in an array of quality assurance, regulatory, inventory management, finance, engineering and distribution jobs, the company said, adding that many of these functions will transition […]
7 medtech stories we missed this week: Sept. 15, 2017
From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention. 1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to […]
7 medtech stories we missed this week: August 11, 2017
From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions […]
Xtant Medical inks licensing deal for Sites Medical’s OsteoSync Ti tech
Xtant Medical (NYSE:XTNT) said today it inked a licensing agreement with Sites Medical for its OsteoSync Ti porous titanium scaffold technology. Sites Medical’s OsteoSync Ti technology is designed with a high friction coefficient for high implant stability and open pore geometry and micro-texturing for bone ingrowth, the company said. “We are very excited to work with Sites […]
MassDevice Network
@MassDevice
LinkedIn
YouTube